Your browser doesn't support javascript.
loading
Erlotinib plus bevacizumab vs erlotinib monotherapy as first-line treatment for advanced EGFR mutation-positive non-squamous non-small-cell lung cancer: Survival follow-up results of the randomized JO25567 study.
Yamamoto, N; Seto, T; Nishio, M; Goto, K; Yamamoto, N; Okamoto, I; Yamanaka, T; Tanaka, M; Takahashi, K; Fukuoka, M.
Affiliation
  • Yamamoto N; Wakayama Medical University, Wakayama, Japan. Electronic address: nbyamamo@wakayama-med.ac.jp.
  • Seto T; National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan. Electronic address: setocruise@gmail.com.
  • Nishio M; The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. Electronic address: mnishio@jfcr.or.jp.
  • Goto K; National Cancer Center Hospital East, Kashiwa, Japan. Electronic address: kgoto@east.ncc.go.jp.
  • Yamamoto N; National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, Japan. Electronic address: nbryamam@ncc.go.jp.
  • Okamoto I; Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Electronic address: okamotoi@kokyu.med.kyushu-u.ac.jp.
  • Yamanaka T; Faculty of Medicine, Yokohama City University, Kanazawa-ku, Yokohama-shi, Kanagawa, Japan. Electronic address: yamanaka@yokohama-cu.ac.jp.
  • Tanaka M; Chugai Pharmaceutical Co. Ltd., Tokyo, Japan. Electronic address: tanaka.misa40@chugai-pharm.co.jp.
  • Takahashi K; Chugai Pharmaceutical Co. Ltd., Tokyo, Japan. Electronic address: takahashikuj@chugai-pharm.co.jp.
  • Fukuoka M; Izumi City General Hospital, Izumi-City, Osaka, Japan. Electronic address: m.fukuoka@tokushukai.jp.
Lung Cancer ; 151: 20-24, 2021 01.
Article in En | MEDLINE | ID: mdl-33279874
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / Erlotinib Hydrochloride / Bevacizumab / Lung Neoplasms Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / Erlotinib Hydrochloride / Bevacizumab / Lung Neoplasms Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2021 Type: Article